ofloxacin has been researched along with d-alpha tocopherol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cheow, WS; Hadinoto, K | 1 |
| Chauhan, A; Gibson, D; Schultz, G; Silva, BO; Ubani-Ukoma, U | 1 |
1 review(s) available for ofloxacin and d-alpha tocopherol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for ofloxacin and d-alpha tocopherol
| Article | Year |
|---|---|
Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Compounding; Drug Delivery Systems; Drug Stability; Lactic Acid; Levofloxacin; Lipids; Microscopy, Electron, Scanning; Nanoparticles; Ofloxacin; Particle Size; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility; Surface-Active Agents; Vitamin E; Water | 2011 |
Evaluating the potential of drug eluting contact lenses for treatment of bacterial keratitis using an ex vivo corneal model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Contact Lenses, Hydrophilic; Cornea; Drug Delivery Systems; Hydrogels; Keratitis; Ofloxacin; Pseudomonas aeruginosa; Rabbits; Silicones; Staphylococcus aureus; Vitamin E | 2019 |